Disc Medicine (IRON) Other Accumulated Expenses (2020 - 2026)

Disc Medicine's (IRON) quarterly Other Accumulated Expenses came in at $870000.0 in Q1 2026, up 71.6% year-on-year from $507000.0 in Q1 2025, and up 23.4% on a QoQ basis from $705000.0 in Q4 2025.

Disc Medicine (IRON) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has 7 years of Other Accumulated Expenses data on file, last reported at $870000.0 in Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 71.6% year-over-year to $870000.0 in Q1 2026; TTM through Mar 2026 was $870000.0, a 71.6% increase from a year earlier, with the FY2025 full-year figure at $705000.0, up 98.59% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $870000.0, up from $705000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for IRON reached as high as $870000.0 in Q1 2026 and fell as low as $52000.0 in Q4 2023.
  • Historically, Other Accumulated Expenses has averaged $390428.6 across 5 years, with a median of $291000.0 in 2023.
  • Across the five-year window, Other Accumulated Expenses soared 880.95% in 2022 and tumbled 74.76% in 2023, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $206000.0 in 2022, then tumbled by 74.76% to $52000.0 in 2023, then surged by 582.69% to $355000.0 in 2024, then surged by 98.59% to $705000.0 in 2025, then increased by 23.4% to $870000.0 in 2026.
  • Per Business Quant data, the three most recent Other Accumulated Expenses figures were $870000.0 in Q1 2026, $705000.0 in Q4 2025, and $749000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,015.37 Bn 1,015.37 Bn -
4 BeOne Medicines 471.39 Bn 466.59 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.52 Bn 115.28 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.33 Bn 61.58 Bn 3.31 Bn
7 Belite Bio 62.74 Bn 62.74 Bn -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn
10 Disc Medicine 2.89 Bn 2.89 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 870,000.00
Dec 31, 2025 705,000.00
Sep 30, 2025 749,000.00
Jun 30, 2025 810,000.00
Mar 31, 2025 507,000.00
Dec 31, 2024 355,000.00
Sep 30, 2024 237,000.00
Jun 30, 2024 188,000.00
Mar 31, 2024 199,000.00
Dec 31, 2023 52,000.00
Sep 30, 2023 54,000.00
Jun 30, 2023 189,000.00
Mar 31, 2023 345,000.00
Dec 31, 2022 206,000.00
Dec 31, 2021 21,000.00
Sep 30, 2021 16,000.00
Jun 30, 2021 147,000.00
Mar 31, 2021 87,000.00
Dec 31, 2020 46,000.00